About this Journal Submit a Manuscript Table of Contents
Case Reports in Emergency Medicine
Volume 2011 (2011), Article ID 242514, 4 pages
http://dx.doi.org/10.1155/2011/242514
Case Report

Green Urine Discoloration due to Propofol Infusion: A Case Report

Department of Critical Care and Emergency, Iwate Prefectural Advanced Critical Care and Emergency Center, Iwate Medical University, 19-1 Uchimaru, Morioka 020-8505, Japan

Received 25 August 2011; Accepted 29 September 2011

Academic Editors: A. K. Exadaktylos, K.-U. Lee, and V. Papadopoulos

Copyright © 2011 Nobuki Shioya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. S. Shim, H. W. Gil, J. O. Yang, E. Y. Lee, S. H. Kim, and S. Y. Hong, “A case of green urine after ingestion of herbicides,” Korean Journal of Internal Medicine, vol. 23, no. 1, pp. 42–44, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Bowling, R. R. Belliveau, and T. J. Butler, “Intravenous medications and green urine,” Journal of the American Medical Association, vol. 246, no. 3, p. 216, 1981. View at Publisher · View at Google Scholar · View at Scopus
  3. S. A. Blakey and J. A. Hixson-Wallace, “Clinical significance of rare and benign side effects: propofol and green urine,” Pharmacotherapy, vol. 20, no. 9 I, pp. 1120–1122, 2000. View at Scopus
  4. C. K. Tan, C. C. Lai, and K. C. Cheng, “Propofol-related green urine,” Kidney International, vol. 74, no. 7, p. 978, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Tirosh, Z. Barzilay, S. Almog, and G. Paret, “Propofol and green urine,” Paediatric anaesthesia, vol. 6, no. 3, p. 244, 1996. View at Scopus
  6. J. Lepenies, E. Toubekis, U. Frei, and R. Schindler, “Green urine after motorcycle accident,” Nephrology Dialysis Transplantation, vol. 15, no. 5, pp. 725–726, 2000. View at Scopus
  7. J. Motsch, H. Schmidt, A. Bach, B. W. Bottiger, and H. Bohrer, “Long-term sedation with propofol and green discolouration of the liver,” European Journal of Anaesthesiology, vol. 11, no. 6, pp. 499–502, 1994. View at Scopus
  8. M. J. Gillett and J. R. Burnett, “Medications and green urine,” Internal Medicine Journal, vol. 36, no. 1, pp. 64–66, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Leclercq, C. Loly, P. Delanaye, C. Garweg, and B. Lambermont, “Green urine,” The Lancet, vol. 373, no. 9673, p. 1462, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Bernante, F. Francini, F. Zangrandi et al., “Green urine after intragastric balloon placement for the treatment of morbid obesity,” Obesity Surgery, vol. 13, no. 6, pp. 951–953, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Ananthanarayan and J. A. Fisher, “Why was the urine green?” Canadian Journal of Anaesthesia, vol. 42, no. 1, pp. 87–88, 1995. View at Scopus
  12. A. Bodenham, L. S. Culank, and G. R. Park, “Propofol infusion and green urine,” Lancet, vol. 2, no. 8561, p. 740, 1987. View at Scopus
  13. C. C. Callander, J. S. Thomas, and C. J. Evans, “Propofol and the colour green,” Anaesthesia, vol. 44, no. 1, p. 82, 1989. View at Scopus
  14. M. Nakao, “Review of intravenous anesthetics and opioids: the anesthetic action, pharmacokinetics and metabolism of propofol,” Rinsho masui, vol. 26, no. 12, pp. 1805–1814, 2002 (Japanese).
  15. Y. Oda, N. Hamaoka, T. Hiroi et al., “Involvement of human liver cytochrome P4502B6 in the metabolism of propofol,” British Journal of Clinical Pharmacology, vol. 51, no. 3, pp. 281–285, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. S. N. de Wildt, G. L. Kearns, J. S. Leeder, and J. N. Van Den Anker, “Glucuronidation in humans,” Clinical Pharmacokinetics, vol. 36, no. 6, pp. 439–452, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Shimizu, Y. Matsumoto, and H. Yamazaki, “Effects of propofol analogs on glucuronidation of propofol, an anesthetic drug, by human liver microsomes,” Drug Metabolism Letters, vol. 1, no. 1, pp. 77–79, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. K. A. McGurk, C. H. Brierley, and B. Burchell, “Drug glucuronidation by human renal UDP-glucuronosyltransferases,” Biochemical Pharmacology, vol. 55, no. 7, pp. 1005–1012, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Favetta, C. S. Degoute, J. P. Perdrix, C. Dufresne, R. Boulieu, and J. Guitton, “Propofol metabolites in man following propofol induction and maintenance,” British Journal of Anaesthesia, vol. 88, no. 5, pp. 653–658, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Zhou and R. Liu, “Does bilirubin change the free concentration of propofol?” Acta Anaesthesiologica Scandinavica, vol. 54, no. 5, pp. 653–654, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. A. McDonagh, “Obstructive jaundice, bilirubin and propofol pharmacodynamics,” Acta Anaesthesiologica Scandinavica, vol. 54, no. 9, p. 1152, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. L. Costela, R. Jiménez, R. Calvo, E. Suárez, and R. Carlos, “Serum protein binding of propofol in patients with renal failure or hepatic cirrhosis,” Acta Anaesthesiologica Scandinavica, vol. 40, no. 6, pp. 741–745, 1996. View at Scopus
  23. E. Suarez, R. Calvo, M. K. Zamacona, J. Lukas, J. X. Mazoit, and K. Sam, “Binding of propofol to blood components,” British Journal of Clinical Pharmacology, vol. 49, no. 4, pp. 380–382, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. J. P. Beller, T. Pottecher, A. Lugnier, P. Mangin, and J. C. Otteni, “Prolonged sedation with propofol in ICU patients: recovery and blood concentration changes during periodic interruptions in infusion,” British Journal of Anaesthesia, vol. 61, no. 5, pp. 583–588, 1988. View at Scopus